188 related articles for article (PubMed ID: 35861118)
21. Trefoil Factor 2 (TFF2) as a Surrogate Marker for Endocervical Gastric-type Carcinoma.
Takako K; Hoang L; Terinte C; Pesci A; Aviel-Ronen S; Alvarado-Cabrero I; Oliva E; Park KJ; Soslow RA; Stolnicu S
Int J Gynecol Pathol; 2021 Jan; 40(1):65-72. PubMed ID: 32897966
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological features and outcomes in gastric-type of HPV-independent endocervical adenocarcinomas.
Chen L; Niu Y; Wan X; Yu L; Zhang X; Strickland AL; Dong L; Zhou F; Lu W
BMC Cancer; 2021 Oct; 21(1):1095. PubMed ID: 34635081
[TBL] [Abstract][Full Text] [Related]
23. Trichorhinophalangeal Syndrome Type 1 Immunohistochemical Expression in Carcinomas of Gynecologic Origin.
Ruiz F; Tjendra Y; Millan N; Gomez-Fernandez C; Pinto A
Am J Surg Pathol; 2024 May; 48(5):546-550. PubMed ID: 38357982
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathologic Association and Prognostic Value of MELF Pattern in Invasive Endocervical Adenocarcinoma (ECA) as Classified by IECC.
Segura SE; Hoang L; Boros M; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Oliva E; Park KJ; Soslow RA; Stolnicu S
Int J Gynecol Pathol; 2020 Sep; 39(5):436-442. PubMed ID: 31517653
[TBL] [Abstract][Full Text] [Related]
25. Cervical adenocarcinoma: integration of HPV status, pattern of invasion, morphology and molecular markers into classification.
Park KJ
Histopathology; 2020 Jan; 76(1):112-127. PubMed ID: 31846527
[TBL] [Abstract][Full Text] [Related]
26. No metastatic cervical adenocarcinomas in a series of p16INK4a-positive mucinous or endometrioid advanced ovarian carcinomas: an analysis of the AGO Ovarian Cancer Study Group.
Wentzensen N; du Bois A; Kommoss S; Pfisterer J; von Knebel Doeberitz M; Schmidt D; Kommoss F
Int J Gynecol Pathol; 2008 Jan; 27(1):18-23. PubMed ID: 18156969
[TBL] [Abstract][Full Text] [Related]
27. Assessment of HER2 in Gastric-Type Endocervical Adenocarcinoma and its Prognostic Significance.
Wang S; Zhou X; Niu S; Chen L; Zhang H; Chen H; Zhou F
Mod Pathol; 2023 Jun; 36(6):100148. PubMed ID: 36841435
[TBL] [Abstract][Full Text] [Related]
28. A Detailed Immunohistochemical Analysis of a Large Series of Cervical and Vaginal Gastric-type Adenocarcinomas.
Carleton C; Hoang L; Sah S; Kiyokawa T; Karamurzin YS; Talia KL; Park KJ; McCluggage WG
Am J Surg Pathol; 2016 May; 40(5):636-44. PubMed ID: 26685087
[TBL] [Abstract][Full Text] [Related]
29. Endometrial endometrioid adenocarcinoma of the uterine corpus involving the cervix: some cases probably represent independent primaries.
Jiang L; Malpica A; Deavers MT; Guo M; Villa LL; Nuovo G; Merino MJ; Silva EG
Int J Gynecol Pathol; 2010 Mar; 29(2):146-56. PubMed ID: 20173500
[TBL] [Abstract][Full Text] [Related]
30. Differential Diagnosis between Primary Endocervical and Endometrial Adenocarcinoma using Immunohistochemical Staining of Estrogen Receptor, Vimentin, Carcinoembryonic Antigen and p16.
Yanaranop M; Ayuwat S; Nakrangsee S
J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S106-15. PubMed ID: 27266224
[TBL] [Abstract][Full Text] [Related]
31. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
[TBL] [Abstract][Full Text] [Related]
32. A panel of 3 markers including p16, ProExC, or HPV ISH is optimal for distinguishing between primary endometrial and endocervical adenocarcinomas.
Kong CS; Beck AH; Longacre TA
Am J Surg Pathol; 2010 Jul; 34(7):915-26. PubMed ID: 20534993
[TBL] [Abstract][Full Text] [Related]
33. p16 Immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection.
Houghton O; Jamison J; Wilson R; Carson J; McCluggage WG
Histopathology; 2010 Sep; 57(3):342-50. PubMed ID: 20727021
[TBL] [Abstract][Full Text] [Related]
34. Cervical carcinomas with serous-like papillary and micropapillary components: illustrating the heterogeneity of primary cervical carcinomas.
Wong RW; Ng JHY; Han KC; Leung YP; Shek CM; Cheung KN; Choi CKM; Tse KY; Ip PPC
Mod Pathol; 2021 Jan; 34(1):207-221. PubMed ID: 32699256
[TBL] [Abstract][Full Text] [Related]
35. Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases.
Coati I; Lotz G; Fanelli GN; Brignola S; Lanza C; Cappellesso R; Pellino A; Pucciarelli S; Spolverato G; Guzzardo V; Munari G; Zaninotto G; Scarpa M; Mastracci L; Farinati F; Realdon S; Pilati P; Lonardi S; Valeri N; Rugge M; Kiss A; Loupakis F; Fassan M
Br J Cancer; 2019 Jul; 121(3):257-263. PubMed ID: 31235864
[TBL] [Abstract][Full Text] [Related]
36. Transforming acidic coiled-coil protein-3: a novel marker for differential diagnosis and prognosis prediction in endocervical adenocarcinoma.
Wen YL; Yan SM; Wei W; Yang X; Zhang SW; Yun JP; Liu LL; Luo RZ
Mol Med; 2021 Jun; 27(1):60. PubMed ID: 34134633
[TBL] [Abstract][Full Text] [Related]
37. A retrospective study on incidence, diagnosis, and clinical outcome of gastric-type endocervical adenocarcinoma in a single institution.
Radomska A; Lee D; Neufeld H; Korte N; Torlakovic E; Agrawal A; Chibbar R
Diagn Pathol; 2021 Jul; 16(1):68. PubMed ID: 34332600
[TBL] [Abstract][Full Text] [Related]
38. Molecular correlates of invasion pattern in HPV-associated endocervical adenocarcinoma: emergence of two distinct risk-stratified tiers.
Sharma AE; Hodgson AJ; Howitt BE; Olkhov-Mitsel E; Djordevic B; Park KJ; Nucci MR; Parra-Herran C
Histopathology; 2023 Jun; 82(7):1067-1078. PubMed ID: 36849702
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemistry and HPV in situ hybridization in pathologic distinction between endocervical and endometrial adenocarcinoma: a comparative tissue microarray study of 76 tumors.
Jones MW; Onisko A; Dabbs DJ; Elishaev E; Chiosea S; Bhargava R
Int J Gynecol Cancer; 2013 Feb; 23(2):380-4. PubMed ID: 23318908
[TBL] [Abstract][Full Text] [Related]
40. mTOR Pathway Activation Assessed by Immunohistochemistry in Cervical Biopsies of HPV-associated Endocervical Adenocarcinomas (HPVA): Correlation With Silva Invasion Patterns.
Segura S; Stolnicu S; Boros M; Park K; Ramirez P; Salvo G; Frosina D; Jungbluth A; Soslow RA
Appl Immunohistochem Mol Morphol; 2021 Aug; 29(7):527-533. PubMed ID: 33587450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
